TY - JOUR
T1 - Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)
AU - Tolleson, Thaddeus R.
AU - Newby, L. Kristin
AU - Harrington, Robert A.
AU - Bhapkar, Manjushri V.
AU - Verheugt, Freek W.A.
AU - Berger, Peter B.
AU - Moliterno, David J.
AU - White, Harvey D.
AU - Ohman, E. Magnus
AU - Van De Werf, Frans
AU - Topol, Eric J.
AU - Califf, Robert M.
N1 - Funding Information:
SYMPHONY and 2nd SYMPHONY were funded by research grants from F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
PY - 2003/8/1
Y1 - 2003/8/1
N2 - We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice.
AB - We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=0042347482&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042347482&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(03)00641-6
DO - 10.1016/S0002-9149(03)00641-6
M3 - Article
C2 - 12888148
AN - SCOPUS:0042347482
VL - 92
SP - 330
EP - 333
IS - 3
ER -